Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Baricitinib is a promising treatment for alopecia areata.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Vorasidenib can cause unusual hair growth.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

An elderly Chinese man lost all his hair after taking a new heart medication.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.